Using Caenorhabditis elegans models of neurodegenerative disease to identify neuroprotective strategies.
Kraemer
Brian
B
Geriatric Research Education and Clinical Center, Veterans Affairs Puget Sound Health Care System, Seattle Division, Seattle, Washington 98108, USA.
Schellenberg
Gerard D
GD
D000818:Animals; D030801:Animals, Genetically Modified; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D017173:Caenorhabditis elegans; D004195:Disease Models, Animal; D006801:Humans; D019636:Neurodegenerative Diseases / Q000188:drug therapy* / Q000473:pathology* / Q000503:physiopathology; D018696:Neuroprotective Agents / Q000494:pharmacology*
D018696:Neuroprotective Agents